Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Pregabalin and Duloxetine in Patients With Painful Diabetic Peripheral Neuropathy (PDPN)
NCT04246619Phase 4Terminated
- Sponsor
- Krka
- Start
- Nov 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 4, randomised, open-label trial in diabetic peripheral neuropathy (DPN) comparing Pregabalin with Duloxetine (2 arms). Primary endpoints: Clinically meaningful improvement of pain in PDPN after a 12 week treatment with pregabalin and Clinically meaningful improvement of pain in PDPN after a 12 week treatment with duloxetine. Started Nov 2019; status: terminated.
02
Drugs
pregabalinduloxetine
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT04246619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04246619.